TNFα antagonists in rheumatoid arthritis patients seen in everyday practice

被引：15

作者：

Falgarone, Geraldine ^{[1
]}

Duclos, Muriel ^{[2
]}

Boissier, Marie-Christophe ^{[2
]}

机构：

[1] Hop Avicenne, Serv Rhumatol, CHU Avicenne, F-93009 Bobigny, France

[2] Univ Paris 13, INSERM ER118, Avicenne Teaching Hosp, Rheumatol Dept,AP HP, Bobigny, France

来源：

JOINT BONE SPINE | 2007年 / 74卷 / 06期

关键词：

TNF alpha antagonists; real-world practice; everyday practice; rheumatoid arthritis;

D O I：

10.1016/j.jbspin.2007.10.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：523 / 526

页数：4

共 35 条

[1]

Askling J, 2007, ANN RHEUM DIS, V66, P54

[2] Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists [J].

Askling, J ;

Fored, CM ;

Baecklund, E ;

Brandt, L ;

Backlin, C ;

Ekbom, A ;

Sundström, C ;

Bertilsson, L ;

Cöster, L ;

Geborek, P ;

Jacobsson, LT ;

Lindblad, S ;

Lysholm, J ;

Rantapää-Dahlqvist, S ;

Saxne, T ;

Klareskog, L ;

Feltelius, N .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1414-1420

[3]

ASKLING J, 2007, ANN RHEUM DIS S2, V66, P162

[4]

Botsios C, 2007, ANN RHEUM DIS, V66, P54

[5] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J].

Breedveld, FC ;

Weisman, MH ;

Kavanaugh, AF ;

Cohen, SB ;

Pavelka, K ;

van Vollenhoven, R ;

Sharp, J ;

Perez, JL ;

Spencer-Green, GT .

ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :26-37

[6]

Brocq O, 2002, PRESSE MED, V31, P1836

[7] Long-term treatment of rheumatoid arthritis with tumour necrosis factor α blockade:: outcome of ceasing and restarting biologicals [J].

Buch, MH ;

Marzo-Ortega, H ;

Bingham, SJ ;

Emery, P .

RHEUMATOLOGY, 2004, 43 (02) :243-244

[8] Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial [J].

Clair, EWS ;

van der Heijde, DMFM ;

Smolen, JS ;

Maini, RN ;

Bathon, JM ;

Emery, P ;

Keystone, E ;

Schiff, M ;

Kalden, JR ;

Wang, B ;

DeWoody, K ;

Weiss, R ;

Baker, D .

ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3432-3443

[9] Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity [J].

Cruyssen, Bert Vander ;

Van Looy, Stijn ;

Wyns, Bart ;

Westhovens, Rene ;

Durez, Patrick ;

Van den Bosch, Filip ;

Mielants, Herman ;

De Clerck, Luc ;

Peretz, Ann ;

Malaise, Michel ;

Verbruggen, Leon ;

Vastesaeger, Nathan ;

Geldhof, Anja ;

Boullart, Luc ;

De Keyser, Filip .

ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)

[10] Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies [J].

Dixon, W. G. ;

Symmons, D. P. M. ;

Lunt, M. ;

Watson, K. D. ;

Hyrich, K. L. ;

Silman, A. J. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :2896-2904

← 1 2 3 4 →